More great news coming from Bayer Co.Lab companies!
Thank you Boston Business Journal and Rowan Walrath for covering Portal's emergence from stealth last week! A quote from the article from our Founder and CEO Armon Sharei, PhD: "A lot of the motivation behind Portal, in addition to broadly enabling the research field, is we truly think #celltherapy will be huge in the long run. Cells are little machines," Sharei said. "If you really enable a simple, robust way to engineer cells, that reduces their cost while also allowing you to do more sophisticated cell engineering. That can really underpin a whole new generation of cell therapies that are more easily accessible and available to bigger patient populations." More in the BBJ here: https://bit.ly/3Nxjt9J #poweredbyportal
